Skip to main content
Tharimmune, Inc. (THAR)
NASDAQ: THAR · IEX Real-Time Price · USD
0.375
+0.012 (3.28%)
At close: May 1, 2024, 3:58 PM
0.380
+0.005 (1.33%)
After-hours: May 1, 2024, 7:54 PM EDT

Tharimmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
404---
Market Cap Growth
--92.07%----
Enterprise Value
-7-11-2221
PE Ratio
-0.04-0.04-0.53---
PB Ratio
0.480.040.81---
P/FCF Ratio
-0.05-0.05-0.69---
P/OCF Ratio
-0.05-0.05-0.69---
EV/EBITDA Ratio
1.141.140.29-1.57-0.76-0.64
EV/EBIT Ratio
1.141.140.29-1.57-0.76-0.64
EV/FCF Ratio
1.451.450.31-1.99-1.54-1.31
Debt / Equity Ratio
----0.46-0.50-0.59
Debt / EBITDA Ratio
----1.57-0.85-0.66
Debt / FCF Ratio
----1.99-1.72-1.36
Quick Ratio
6.026.025.690.000.070.03
Current Ratio
6.036.035.840.140.110.04
Interest Coverage
-563.62-563.62-4.32-1.65-8.81-19.32
Return on Equity (ROE)
-217.30%-217.30%-105.80%52.50%90.50%-
Return on Assets (ROA)
-159.10%-159.10%-95.00%-481.60%-1440.30%-
Return on Capital (ROIC)
-103.55%-103.55%-124.14%127.33%96.85%216.13%
Earnings Yield
-211.68%-2613.75%-188.53%---
FCF Yield
-165.82%-2047.48%-145.92%---
Buyback Yield / Dilution
-188.38%-188.38%-78.02%-0.16%-69.08%-
Total Shareholder Return
-188.38%-188.38%-78.02%-0.16%-69.08%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).